Pharmaceutical Information |
Drug Name |
Methohexital sodium |
Drug ID |
BADD_D01417 |
Description |
An intravenous anesthetic with a short duration of action that may be used for induction of anesthesia. |
Indications and Usage |
Methohexital is indicated for use as an intravenous anaesthetic. It has also been commonly used to induce deep sedation. |
Marketing Status |
Prescription; Discontinued |
ATC Code |
N01AF01; N05CA15 |
DrugBank ID |
DB00474
|
KEGG ID |
D00712
|
MeSH ID |
D008723
|
PubChem ID |
23690443
|
TTD Drug ID |
D0S8TD
|
NDC Product Code |
42023-105 |
Synonyms |
Methohexital | Methohexitone | Brevimytal Natrium | Natrium, Brevimytal | Brietal-Sodium | Brietal Sodium | Methohexital Sodium | Sodium, Methohexital | Methohexital, Monosodium Salt | Monosodium Salt Methohexital | Brevital | Brietal |
|
Chemical Information |
Molecular Formula |
C14H17N2NaO3 |
CAS Registry Number |
309-36-4 |
SMILES |
CCC#CC(C)C1(C(=O)N=C(N(C1=O)C)[O-])CC=C.[Na+] |
Chemical Structure |
|
|
ADR Related Proteins Induced by Drug |
ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
Not Available | Not Available | Not Available | Not Available | Not Available |
|
ADRs Induced by Drug |
ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Cardiovascular insufficiency | 24.06.03.005; 02.01.01.011 | - | - | Not Available |
|
|
|